Medical Genome Center revealed. The University of Glasgow studied hybrid viruses. which is mixed with covid and influenza but only in the laboratory Revealing that the major vaccine manufacturers are preparing to give birth 1 needle to cover the entire virus.
October 27, 2022 – Genome Medical Center Faculty of Medicine Ramathibodi Hospital Mahidol University Facebook Post Worried or Not “Hybrid Viruses” are formed by the fusion of two types of viral particles: It has been discovered that the “RSV virus” and the “flu virus” evade the immune system well against the flu virus.
Research Group of the University of Glasgow Two types of viruses were tested in England: RSV (Respiratory Syncytial Virus) and influenza viruses Both RNA viruses (Figure 1) were grown together with the same lung cells grown in vitro. It appears that instead of both types of viruses competing to infiltrate the cell, there is a possibility that another type of virus follows. As in the case of the 2019 coronavirus, the particle wall of RSV and influenza viruses has been found.They are fused with separate genomes. become a new type of hybrid virus Palm-shaped: RSV virus looks like a trunk. The leaves come from the influenza virus (Figure 2). The original morphology of the RSV virus particles observed through an electron microscope revealed a variety of shapes such as spherical, elongated and asymmetrical. while the flu virus Most are spherical or elliptical (Figure 3).
In vitro tests revealed that the RSV virus and the influenza virus were hybrids. Access to a wider range of target cells Because the influenza virus is originally transmitted in the upper respiratory tract. such as the cells of the nose, throat and trachea, while RSV invades the lower respiratory tract. bronchial and lung cells which is a major cause of pneumonia in young children and the elderly This leads to hospitalizations and thousands of deaths each year. But it is believed that in vitro hybrid viruses, if they can spread to humans, are capable of infecting the nose, throat, trachea and lungs. RSV, or just one type of influenza virus.
Hybrid viruses are capable of infecting neighboring cells even where antibodies to the influenza virus are present which normally prevent influenza virus infection from entering the cells. Under the microscope, the researchers looked at antibodies attached to the hybrid viral sheath at the site of the influenza virus. But hybrid viruses can also use cortical proteins in nearby RSV viral segments to bind to the lung surface and still infiltrate. It showed that the hybrid virus particles relied on the RSV sheath which blocks antibodies like a Trojan horse, leading the influenza virus to evade immunity in cells.
But don’t be so quick to worry. Because we only found the hybrid virus in the University of Glasgow laboratory. There have been no reports of this type of hybrid virus being found to cause disease in humans.
Major vaccine companies are also ramping up production of an mRNA combination vaccine among the coronavirus. 2019-Influenza virus-RSV as single-dose injection to young children and the elderly to prevent respiratory infections caused by the virus. Phase I of the clinical trial will begin in late 2022. Preliminary animal data show that it can boost immunity to all three types of viruses simultaneously. which should be able to prevent infection with coronavirus 2019-influenza virus-virus hybrid virus also RSV
Therefore, hybrid viral outbreaks, if they occur in the future, could be difficult to transmit in children who were vaccinated with the combination vaccine during the coronavirus. 2019-flu virus-RSV virus
https://www.nature.com/articles/s41564-022-01242-5
https: //www.theguardian.com /…/ immune-system-evading …
https: //www.pharmacytimes.com /…/ combination-flu-covid …
